Annual EBITDA
-$741.79M$365.63M-97.20%
Summary
- Current Value
- As of today, RNA annual EBITDA is -$741.79M, down -97.20% on
- Historical Performance
- RNA annual EBITDA is down -317.85% over the past 3 years, down -1589.58% over the past 5 years
- All-Time High Comparison
- RNA annual EBITDA is currently -7233.58% below its historical high of -$10.12M set on
- 3-Year Low Comparison
- RNA annual EBITDA is at its 3-year low
- Sector Comparison
- RNA annual EBITDA is higher than 0.77% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$741.79M | -97.2% | -317.9% | -1589.6% | -7233.6% | |
| Quarterly EBITDA | -$252.98M | -110.4% | -378.7% | -1463.7% | -10000.0% | |
| TTM EBITDA | -$252.98M | +32.8% | -42.5% | -476.2% | -10000.0% | |
| Price | $12.99 | – | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $18.62M | +70.8% | +101.8% | +174.3% | +4812.4% | |
| Annual EPS | -$2.89 | -97.0% | +13.3% | -41.3% | -867.4% | |
| -$745.94M | -96.8% | -316.9% | -1584.7% | -7005.6% | ||
| Annual Net Income | -$49.50M | -97.0% | +71.5% | -11.6% | -341.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$177.53M | N/A | -317.9% |
| 5Y | -$43.90M | N/A | -1589.6% |
| All | -$10.12M | -7233.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$741.79M | at low | |
| 5Y | -$741.79M | at low | |
| All | -$741.79M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$741.79M | -97.2% | |
| -$376.16M | -61.1% | |
| -$233.50M | -31.5% | |
| -$177.53M | -51.2% |
| Year | Value | Change |
|---|---|---|
| -$117.41M | -167.4% | |
| -$43.90M | -162.3% | |
| -$16.74M | -65.4% | |
| -$10.12M | - |
FAQ
What is the current annual EBITDA of RNA?
As of today, RNA annual EBITDA is -$741.79M
What is 1-year change in RNA annual EBITDA?
RNA annual EBITDA is down -97.20% year-over-year
What is 3-year change in RNA annual EBITDA?
RNA annual EBITDA is down -317.85% over the past 3 years
How far is RNA annual EBITDA from its all-time high?
RNA annual EBITDA is currently -7233.58% below its historical high of -$10.12M set on December 31, 2018
How does RNA annual EBITDA rank versus sector peers?
RNA annual EBITDA is higher than 0.77% of companies in Healthcare sector
When is RNA next annual earnings release?
As of today, the next annual earnings release for RNA has not been scheduled
Quarterly EBITDA
-$252.98M
Summary
- Current Value
- As of today, RNA quarterly EBITDA is -$252.98M, with unknown change on
- Historical Performance
- RNA quarterly EBITDA is down -110.38% year-over-year, down -378.73% over the past 3 years
- All-Time High Comparison
- RNA quarterly EBITDA is currently -12423.86% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA quarterly EBITDA is at its 3-year low
- Sector Comparison
- RNA quarterly EBITDA is higher than 0.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$252.98M | – | -110.4% | -378.7% | -1463.7% | |
| Annual EBITDA | -$741.79M | – | -97.2% | -317.9% | -1589.6% | |
| TTM EBITDA | -$252.98M | – | +32.8% | -42.5% | -476.2% | |
| Price | $12.99 | – | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $859.00K | – | -71.1% | -69.0% | -59.9% | |
| Quarterly EPS | -$1.70 | – | -153.1% | -93.3% | -291.8% | |
| -$254.48M | – | -110.3% | -378.1% | -1461.9% | ||
| Quarterly Net Income | -$29.14M | – | -153.1% | +42.3% | -79.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$120.25M | N/A | -110.4% |
| 3Y | -$51.37M | -392.4% | |
| 5Y | -$23.75M | N/A | -965.2% |
| All | -$2.02M | >-9999.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$252.98M | at low | |
| 3Y | -$252.98M | at low | |
| 5Y | -$252.98M | at low | |
| All | -$252.98M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RNA?
As of today, RNA quarterly EBITDA is -$252.98M
What is RNA quarterly EBITDA most recent change?
RNA quarterly EBITDA change on December 31, 2025 is unknown
What is 1-year change in RNA quarterly EBITDA?
RNA quarterly EBITDA is down -110.38% year-over-year
How far is RNA quarterly EBITDA from its all-time high?
RNA quarterly EBITDA is currently -12423.86% below its historical high of -$2.02M set on March 31, 2019
How does RNA quarterly EBITDA rank versus sector peers?
RNA quarterly EBITDA is higher than 0.74% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
TTM EBITDA
-$252.98M
Summary
- Current Value
- As of today, RNA TTM EBITDA is -$252.98M, with unknown change on
- Historical Performance
- RNA TTM EBITDA is up +32.75% year-over-year, down -42.51% over the past 3 years
- All-Time High Comparison
- RNA TTM EBITDA is currently -12423.86% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA TTM EBITDA is +32.75% above its 3-year low of -$376.16M reached on
- Sector Comparison
- RNA TTM EBITDA is higher than 5.53% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$252.98M | – | +32.8% | -42.5% | -476.2% | |
| Annual EBITDA | -$741.79M | – | -97.2% | -317.9% | -1589.6% | |
| Quarterly EBITDA | -$252.98M | – | -110.4% | -378.7% | -1463.7% | |
| Price | $12.99 | – | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $859.00K | – | -92.1% | -90.7% | -87.3% | |
| TTM EPS | -$1.70 | – | +38.7% | +48.8% | -43.8% | |
| -$254.48M | – | +32.8% | -42.2% | -474.7% | ||
| TTM Net Income | -$29.14M | – | +87.4% | +83.3% | +34.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$252.98M | at high | |
| 3Y | -$199.89M | N/A | -26.6% |
| 5Y | -$61.64M | N/A | -310.4% |
| All | -$2.02M | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$376.16M | N/A | +32.8% |
| 3Y | -$376.16M | +32.8% | |
| 5Y | -$376.16M | +32.8% | |
| All | -$376.16M | +32.8% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RNA?
As of today, RNA TTM EBITDA is -$252.98M
What is RNA TTM EBITDA most recent change?
RNA TTM EBITDA change on December 31, 2025 is unknown
What is 1-year change in RNA TTM EBITDA?
RNA TTM EBITDA is up +32.75% year-over-year
How far is RNA TTM EBITDA from its all-time high?
RNA TTM EBITDA is currently -12423.86% below its historical high of -$2.02M set on March 31, 2019
How does RNA TTM EBITDA rank versus sector peers?
RNA TTM EBITDA is higher than 5.53% of companies in Healthcare sector
When is RNA next earnings release?
The next earnings release for RNA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RNA Official Website www.atriumtherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna